Skip to main content
Fig. 3 | Journal of Neuroinflammation

Fig. 3

From: Recombinant human plasma gelsolin reverses increased permeability of the blood–brain barrier induced by the spike protein of the SARS-CoV-2 virus

Fig. 3

Plasma gelsolin reverses the destructive effect of SARS-CoV-2 Spike protein S1 subunit on blood–brain barrier function in the 3D flow model. Confocal images of hCMEC/D3 cells (panel A), tight junction protein ZO-1 (red), and nuclei (blue). Permeability coefficient measured from dextran experiments for endothelial channels exposed to S1 and S1 + pGSN (Panel B). TEER measurement results (Panel C). Images demonstrating the measurement of vessel permeability using 4 kDa FITC-dextran (green) and the effects of the S1 and S1 + pGSN (Panel D). Barrier permeability and TEER measurement were performed after 4 h of perfusion with 10 nM of S1 and S1 + pGSN. The data represent the mean ± SEM of four independent experiments (n = 4). * and ^ indicate statistical significance at p ≤ 0.05 compared to CT and S1, respectively, by one-way ANOVA and Tukey post hoc test

Back to article page